Ingham Regional Medical Center's Great Lakes Cancer Institute-Breslin Cancer Center is one of 435 sites in the country to recruit people for the SELECT trial. The 12-year study will find out if Selenium and Vitamin C can prevent prostate cancer.
You can participate in the SELECT trial if:
Prostate Cancer Screenings will take place at the Breslin Cancer Center as well:
Wednesday, Sept. 18
12 - 4 p.m. and 5- 8 p.m.
Wednesday, Sept. 25
5 – 8 p.m.
wilx.com: Extended Web Coverage
Who is at Risk for Prostate Cancer?
Prostate cancer is the most common cancer in North American men after skin cancer. It is the second leading cause of cancer death in men after lung cancer.
Both the number of new cases of prostate cancer and the number of deaths due to prostate cancer have increased in the past decade.
Anything that increases a person's chance of developing a disease is called a risk factor. Some of these risk factors for prostate cancer are:
Race - Black males are more likely to develop prostate cancer than white males. Black males are also more likely to die of prostate cancer than white males.
Family History of Prostate Cancer - A man whose father, brother, or son has had prostate cancer has a higher-than-average risk of developing prostate cancer.
Other potential risk factors include alcohol consumption, vitamin or mineral interactions, and other dietary habits.
Source: http://cancernet.nci.nih.gov/cgi-bin/srchcgi.exe?DBID=pdq&TYPE=search&UID=280+02606&ZFILE=patient&SFMT=pdq_scrprv/1/0/0 (National Cancer Institute).